BPG is committed to discovery and dissemination of knowledge
Editorial
©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Aug 26, 2019; 9(4): 58-61
Published online Aug 26, 2019. doi: 10.5500/wjt.v9.i4.58
Blessing and a curse of outpatient management of delayed graft function
Justin W Blazel, Jennifer A Turk, Brenda L Muth, Sandesh Parajuli
Justin W Blazel, Jennifer A Turk, Brenda L Muth, Sandesh Parajuli, Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, United States
Author contributions: Blazel JB designed and prepared the manuscript; Turk JA edited the manuscript; Muth BL designed and edited the manuscript; Parajuli S concept, designed and edited manuscript.
Conflict-of-interest statement: The authors have no conflict of interest to declare.
Corresponding author: Sandesh Parajuli, MBBS, MD, Assistant Professor, Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, UW Medical Foundation Centennial Building 4175, 1685 Highland Avenue, Madison, WI 53705, United States. sparajuli@medicine.wisc.edu
Telephone: +1-608-2650152
Received: March 21, 2019
Peer-review started: March 24, 2019
First decision: June 7, 2019
Revised: July 13, 2019
Accepted: August 6, 2019
Article in press: August 7, 2019
Published online: August 26, 2019
Processing time: 152 Days and 13.4 Hours
Core Tip

Core tip: Delayed graft function (DGF), traditionally defined as needing dialysis within seven days following kidney transplant, occurs most often after deceased donor kidney transplantation. Both donor characteristics, as well as immunologic factors, influence the development of DGF. Historically, outpatient management has been difficult, often leading to increased length of stay (LOS), however, the DGF clinic at University of Wisconsin - Madison which was established in 2011 has shown that it is possible to provide high-quality outpatient DGF management without increasing LOS, 30-d readmission, or acute rejection rates.